233 related articles for article (PubMed ID: 24501405)
21. Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
Hulme AE; Kelley Z; Foley D; Hope TJ
J Virol; 2015 May; 89(10):5350-61. PubMed ID: 25741002
[TBL] [Abstract][Full Text] [Related]
22. Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.
Murer L; Petkidis A; Vallet T; Vignuzzi M; Greber UF
J Virol; 2022 Jan; 96(2):e0106021. PubMed ID: 34705560
[TBL] [Abstract][Full Text] [Related]
23. Identification and Characterization of a Poliovirus Capsid Mutant with Enhanced Thermal Stability.
Nguyen Y; Jesudhasan PR; Aguilera ER; Pfeiffer JK
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567995
[TBL] [Abstract][Full Text] [Related]
24. Dengue Virus Genome Uncoating Requires Ubiquitination.
Byk LA; Iglesias NG; De Maio FA; Gebhard LG; Rossi M; Gamarnik AV
mBio; 2016 Jun; 7(3):. PubMed ID: 27353759
[TBL] [Abstract][Full Text] [Related]
25. Attachment of neutralizing antibodies stabilizes the capsid of poliovirus against uncoating.
Wetz K
Virology; 1993 Feb; 192(2):465-72. PubMed ID: 8380661
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the poliovirus 147S particle: new insights into poliovirus uncoating.
Pelletier I; Ouzilou L; Arita M; Nomoto A; Colbère-Garapin F
Virology; 2003 Jan; 305(1):55-65. PubMed ID: 12504541
[TBL] [Abstract][Full Text] [Related]
27. Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor.
Chen Z; Fischer ER; Kouiavskaia D; Hansen BT; Ludtke SJ; Bidzhieva B; Makiya M; Agulto L; Purcell RH; Chumakov K
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20242-7. PubMed ID: 24277851
[TBL] [Abstract][Full Text] [Related]
28. Alanine scanning of poliovirus 2CATPase reveals new genetic evidence that capsid protein/2CATPase interactions are essential for morphogenesis.
Wang C; Jiang P; Sand C; Paul AV; Wimmer E
J Virol; 2012 Sep; 86(18):9964-75. PubMed ID: 22761387
[TBL] [Abstract][Full Text] [Related]
29. A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment.
Lee H; Brendle SA; Bywaters SM; Guan J; Ashley RE; Yoder JD; Makhov AM; Conway JF; Christensen ND; Hafenstein S
J Virol; 2015 Jan; 89(2):1428-38. PubMed ID: 25392224
[TBL] [Abstract][Full Text] [Related]
30. A simple quantitative affinity capturing assay of poliovirus antigens and subviral particles by single-domain antibodies using magnetic beads.
Thys B; Saerens D; Schotte L; De Bleeser G; Muyldermans S; Hassanzadeh-Ghassabeh G; Rombaut B
J Virol Methods; 2011 May; 173(2):300-5. PubMed ID: 21371506
[TBL] [Abstract][Full Text] [Related]
31. Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.
Viktorova EG; Khattar SK; Kouiavskaia D; Laassri M; Zagorodnyaya T; Dragunsky E; Samal S; Chumakov K; Belov GA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925653
[TBL] [Abstract][Full Text] [Related]
32. An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.
Dove AW; Racaniello VR
J Virol; 2000 Apr; 74(8):3929-31. PubMed ID: 10729171
[TBL] [Abstract][Full Text] [Related]
33. Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.
Wang X; Ku Z; Zhang X; Ye X; Chen J; Liu Q; Zhang W; Zhang C; Fu Z; Jin X; Cong Y; Huang Z
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070691
[TBL] [Abstract][Full Text] [Related]
34. Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions.
Mosser AG; Sgro JY; Rueckert RR
J Virol; 1994 Dec; 68(12):8193-201. PubMed ID: 7966611
[TBL] [Abstract][Full Text] [Related]
35. New small-molecule inhibitors effectively blocking picornavirus replication.
Ford Siltz LA; Viktorova EG; Zhang B; Kouiavskaia D; Dragunsky E; Chumakov K; Isaacs L; Belov GA
J Virol; 2014 Oct; 88(19):11091-107. PubMed ID: 25008939
[TBL] [Abstract][Full Text] [Related]
36. Stabilization of poliovirus by capsid-binding antiviral drugs is due to entropic effects.
Tsang SK; Danthi P; Chow M; Hogle JM
J Mol Biol; 2000 Feb; 296(2):335-40. PubMed ID: 10669591
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of poliovirus uncoating in HeLa cells in a nonacidic environment.
Gromeier M; Wetz K
J Virol; 1990 Aug; 64(8):3590-7. PubMed ID: 2164587
[TBL] [Abstract][Full Text] [Related]
38. Use of drug-resistance mutants to identify functional regions in picornavirus capsid proteins.
Mosser AG; Shepard DA; Rueckert RR
Arch Virol Suppl; 1994; 9():111-9. PubMed ID: 8032243
[TBL] [Abstract][Full Text] [Related]
39. Real-Time Imaging of Polioviral RNA Translocation across a Membrane.
Karunatilaka KS; Filman DJ; Strauss M; Loparo JJ; Hogle JM
mBio; 2021 Feb; 12(1):. PubMed ID: 33622727
[TBL] [Abstract][Full Text] [Related]
40. Nanobody-Mediated Neutralization Reveals an Achilles Heel for Norovirus.
Koromyslova AD; Devant JM; Kilic T; Sabin CD; Malak V; Hansman GS
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
